IDEAYA Biosciences enters clinical collaboration with Genentech
IDEAYA Biosciences (IDYA) announces a clinical collaboration with Genentech focused on MTAP-deleted KRAS G12D-mutant pancreatic cancer.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.